Exagen Inc expected to post a loss of 43 cents a share - Earnings Preview

Exagen

15/03/2024 13:01

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a fall in
quarterly revenue when it reports  results on March 18 for the
period ending December 31 2023
    * The Vista California-based  company is expected to report
a
9.9% decrease in revenue to $11.562 million from $12.84 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Exagen Inc is for a loss
of 43
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Exagen Inc
is
$5.50​, above​ its last closing price of $1.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.46       -0.47      -0.31     Beat    34
 Jun. 30 2023  -0.50       -0.49      -0.28     Beat    43.4
 Mar. 31 2023  -0.57       -0.56      -0.44     Beat    21.7​
 Dec. 31 2022  -0.81       -0.78      -0.83     Missed  -6.4
 ​​Sep.        -0.73       -0.73      -0.47     Beat    35.6
 30 2022                                                
 Jun. 30 2022  -0.57       -0.57      -0.78     Missed  -36.8​
 Mar. 31 2022  -0.61       -0.61      -0.60     Beat    1.4
 Dec. 31 2021  -0.44       -0.50      -0.42     Beat    15.4
 This summary was machine generated March 15 at 13:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)